CAR T-Cell Therapy in Systemic Lupus Erythematosus: Mechanistic Rationale, Early Clinical Experience, and Future Challenges

Sabarinath Mahadevan, Saranya Chinnadurai, Balakrishnan Navaneethakrishnan

Open source

DOI
10.31138/mjr.171125.mer
Published
2026
Container
Mediterranean Journal of Rheumatology
Publisher
Convin SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.31138/mjr.171125.mer,
  title = {CAR T-Cell Therapy in Systemic Lupus Erythematosus: Mechanistic Rationale, Early Clinical Experience, and Future Challenges},
  author = {Sabarinath Mahadevan and Saranya Chinnadurai and Balakrishnan Navaneethakrishnan},
  year = {2026},
  journal = {Mediterranean Journal of Rheumatology},
  doi = {10.31138/mjr.171125.mer},
  url = {https://doi.org/10.31138/mjr.171125.mer}
}

RIS

TY  - JOUR
TI  - CAR T-Cell Therapy in Systemic Lupus Erythematosus: Mechanistic Rationale, Early Clinical Experience, and Future Challenges
AU  - Sabarinath Mahadevan
AU  - Saranya Chinnadurai
AU  - Balakrishnan Navaneethakrishnan
PY  - 2026
JO  - Mediterranean Journal of Rheumatology
DO  - 10.31138/mjr.171125.mer
UR  - https://doi.org/10.31138/mjr.171125.mer
ER  - 

APA

Mahadevan, S., Chinnadurai, S., & Navaneethakrishnan, B. (2026). CAR T-Cell Therapy in Systemic Lupus Erythematosus: Mechanistic Rationale, Early Clinical Experience, and Future Challenges. Mediterranean Journal of Rheumatology. https://doi.org/10.31138/mjr.171125.mer

Source records